CAR-T Following ASCT for Relapsed/Refractory B-Cell Non-Hodgkin ' s Lymphoma (R/R B-NHL) With High-Risk Prognostic Factors

Conditions: B-NHL, Extranodal, TP53 Alterations, Bulky Mass Interventions: Biological: autologous stem-cell transplantation, Relmacabtagene autoleucel (relma-cel) Sponsors: Ruijin Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials